But most tumor entities fail to produce the critical effector cytokine TNF upon SM exposure.5 We hypothesized that hypertonicity-derived TNF could compensate for absent autocrine TNF production in SM-resistant cells and reinstate cytotoxicity of SM monotherapies. This evidence concerns the gene TNF and neoplasm.